CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

JOURNAL ARTICLE published October 2011 in The Lancet Oncology

Authors: Michael Pfreundschuh | Evelyn Kuhnt | Lorenz Trümper | Anders Österborg | Marek Trneny | Lois Shepherd | Devinder S Gill | Jan Walewski | Ruth Pettengell | Ulrich Jaeger | Pier-Luigi Zinzani | Ofer Shpilberg | Stein Kvaloy | Peter de Nully Brown | Rolf Stahel | Noel Milpied | Armando López-Guillermo | Viola Poeschel | Sandra Grass | Markus Loeffler | Niels Murawski